key: cord-0808992-q3vquuva authors: Giacomet, Vania; Stracuzzi, Marta; Paradiso, Laura; Di Cosimo, Maria Elisabetta; Rubinacci, Valeria; Zuccotti, GianVincenzo title: Defining the clinical phenotype of COVID‐19 in children date: 2020-11-24 journal: Pediatr Allergy Immunol DOI: 10.1111/pai.13355 sha: d432dece028d4e3e8551db111e41228395716c14 doc_id: 808992 cord_uid: q3vquuva On January 7, 2020, a novel coronavirus (SARS‐CoV‐2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS‐CoV‐2 discovery, the corresponding disease (COVID‐19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID‐19 had been confirmed worldwide, with more than 318.599 deaths. On January 7, 2020, a novel coronavirus (SARS-CoV-2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS-CoV-2 discovery, the corresponding disease (COVID-19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID-19 had been confirmed worldwide, with more than 318.599 deaths. 1 A global effort has been made to collect clinical and laboratory findings on patients with SARS-CoV-2 infection. The lower airway is the primary target of the infection; however, the disease spectrum goes from asymptomatic subjects to severe illness, including 5.0% subjects requiring ICU admission, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. 2 Available reports show that children are less likely than other age groups to develop severe symptoms when infected by SARS-CoV-2. [3] [4] [5] [6] [7] Although there is some evidence of differences in the infection prevalence between adults and children, data gathered from contact tracing investigation on a large cohort show that the secondary infection rate after exposure to the virus is no different in children and they are just as likely to become infected as other age groups. 8 In the early phase of the infection outbreak, transmission source in children was not easily identifiable; during the last period, virus exposure has been caused by household contact. Preliminary clinical findings in China showed that infected children tend to be asymptomatic or paucisymptomatic compared to adult cases, whereas their role in the transmission dynamics is still unclear. 9 The most common symptoms reported were fever, cough, and rhinorrhea. Gastrointestinal symptoms as hypoalimentation, vomiting, abdominal pain, and diarrhea were also common. 3,6 Estimated asymptomatic infection rates range from 1.3% to 12.9% 4-10 ; 60%- Chest X-ray or chest TC was generally performed on admission and usually found infiltrates bilateral or mono-lateral, and sometimes atelectasis or pleural effusion. Of note, not all symptomatic patients had radiologic signs of pneumonia. Many authors report that the main radiologic features are bronchial thickening, groundglass opacity, or inflammatory lung lesions, suggestive of pneumonia. These pulmonary findings were also found in patients with mild symptoms or asymptomatic, suggesting that COVID-19 induces a primary inflammation of the lower respiratory tract airways. An essential role in children diagnostics could be played by lung ultrasound (LUS). Preliminary data suggest high concordance between radiologic and LUS findings in detecting lung abnormalities in children with COVID-19. 12 Few laboratory abnormalities were observed in COVID-19 children, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] All these data are far from being scientifically established, they remain anecdotal, and need to be systematically organized according to a clinical severity score. Admission to PICU has occurred between 1.8% and 9.7% of patients according to available recent data [3] [4] [5] [6] [7] ; the most significant co- In an Italian case report, 16 authors confirm these new concerns about a novel severe Kawasaki-like disease in children related to COVID-19, reporting a monthly incidence some 30-fold higher than observed for Kawasaki disease in the last 5 years. Debates among pediatricians, infectious disease specialists, rheumatologists, immunologists, and cardiologists regard how this new phenotype could be interpreted: Is it a "pediatric inflammatory Children are less likely than other age groups to develop se- multisystem temporally associated with SARS-CoV-2 (PIMS-TS)", 17 requiring critical care and underlining a severe spectrum of the disease or a "postinfectious inflammatory syndrome, maybe due to antibody or immune-complex-mediated process" as we see in the Italian cohort? As we can see, we are far from understanding the clinical spectrum of this new emerging disease. Investigating the pediatric population could be challenging to study for different reasons. In the early phase of the COVID-19 outbreak, many authors suggested that children were less likely susceptible to SARS-CoV-2 infection, assuming immunopathogenic theories that are yet to be confirmed; subsequently, we understood that children could be infected in similar rates when compared to the adult population. Now, as many reports and clinical data are being published, we become aware of possible severe and critical cases among children, but with clinical manifestations different from what has been seen in adults. More studies are needed in order to understand the pathogenetic pathways of SARS-CoV-2 infection in children. The authors have no competing interests to declare. The peer review history for this article is available at https://publo ns.com/publo n/10.1111/pai.13355. https://orcid.org/0000-0002-0892-9039 An interactive web-based dashboard to track COVID-19 in real time Clinical features of patients infected with 2019 novel coronavirus in Wuhan Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 Epidemiology of COVID-19 among children in China Characteristics and outcomes of children with Coronavirus Disease 2019 (COVID-19) infection admitted to US and Canadian Pediatric intensive care units Children with Covid-19 in Pediatric Emergency Departments in Italy Screening and severity of coronavirus disease 2019 (COVID-19) in children in Epidemiology and transmission of COVID-19 in shenzhen China: Analysis of 391 cases and 1,286 of their close contacts COVID-19 in children: the link in the transmission chain Coronavirus disease 2019 in Children -United States Special Issues for COVID-19 in Children and Adolescents Lung ultrasound in children With COVID-19 Laboratory abnormalities in children with novel coronavirus disease 2019 Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavirus disease in China Hyperinflammatory shock in children during COVID-19 pandemic Articles An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic : an observational cohort study Comment Kawasaki-like disease : emerging complication during the COVID-19 pandemic Defining the clinical phenotype of COVID-19 in children